C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet

Diabetologia

Volumn 50, Issue 6, 2007, Pages 1267-1276

  Poggi, M ^a   Bastelica, D ^a   Gual, P ^a   Iglesias, M A ^b   Gremeaux, T ^a   Knauf, C ^b   Peiretti, F ^a   Verdier, M ^a   Juhan Vague, I ^a   Tanti, J F ^a   Burcelin, R ^b   Alessi, M C ^a  

^a INSERM   (France)

^b CNRS   (France)

Author keywords

Adipose tissue; High fat diet; Insulin resistance; Lipid metabolism; Liver steatosis; Obesity; TLR4; Toll like receptor 4

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; TOLL LIKE RECEPTOR 4; UNCOUPLING PROTEIN 1;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; EPIDIDYMIS FAT; FATTY LIVER; FOOD INTAKE; GENE MUTATION; HETEROZYGOTE; INFLAMMATORY INFILTRATE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPOGENESIS; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRIACYLGLYCEROL BLOOD LEVEL; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; DIETARY FATS; GLYCOLYSIS; INFLAMMATION; INSULIN RESISTANCE; LIPIDS; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MUTATION; POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 4; TRIGLYCERIDES;

EID: 34247884376     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0654-8     Document Type: Article

References (51)

1. Festa A, D'Agostino R Jr, Howard G et al (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42-47
2. Wellen KE, Hotamisligil GS (2005) Inflammation, stress, and diabetes. J Clin Invest 115:1111-1119
3. Xu H, Barnes GT, Yang Q et al (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830
4. Langhans W (2000) Anorexia of infection: current prospects. Nutrition 16:996-1005
5. Nolan JP, Hare DK, McDevitt JJ, Ali MV (1977) In vitro studies of intestinal endotoxin absorption. I. Kinetics of absorption in the isolated everted gut sac. Gastroenterology 72:434-439
6. Wiedermann CJ, Kiechl S, Dunzendorfer S et al (1999) Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the bruneck study. J Am Coll Cardiol 34:1975-1981
7. Stoll LL, Denning GM, Weintraub NL (2004) Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler Thromb Vasc Biol 24:2227-2236
8. Van der Poll T, Braxton CC, Coyle SM et al (1995) Effect of hypertriglyceridemia on endotoxin responsiveness in humans. Infect Immun 63:3396-3400
9. McClain C, Hill D, Schmidt J, Diehl AM (1993) Cytokines and alcoholic liver disease. Semin Liver Dis 13:170-182
10. Vyberg M, Ravn V, Andersen B (1987) Pattern of progression in liver injury following jejunoileal bypass for morbid obesity. Liver 7:271-276
11. Roden M (2006) Mechanisms of disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2:335-348
12. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM (1997) Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 94:2557-2562
13. Pappo I, Becovier H, Berry EM, Freund HR (1991) Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat. J Surg Res 51:106-112
14. Li Z, Soloski MJ, Diehl AM (2005) Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 42:880-885
15. Kolek MJ, Carlquist JF, Muhlestein JB et al (2004) Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes. Am Heart J 148:1034-1040
16. Illig T, Bongardt F, Schopfer A et al (2003) The endotoxin receptor TLR4 polymorphism is not associated with diabetes or components of the metabolic syndrome. Diabetes 52:2861-2864
17. Takeda K (2005) Evolution and integration of innate immune recognition systems: the toll-like receptors. J Endotoxin Res 11:51-55
18. Lin Y, Lee H, Berg AH et al (2000) The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem 275:24255-24263
19. Bes-Houtmann S, Roche R, Hoareau L et al (2007) Presence of functional TLR2 and TLR4 on human adipocytes. Histochem Cell Biol 127:131-137
20. Poltorak A, He X, Smirnova I et al (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088
21. Declerck PJ, Verstreken M, Collen D (1995) Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice. Thromb Haemost 74:1305-1309
22. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509
23. Burcelin R, DolciW, Thorens B (2000) Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes 49:1635-1642
24. Burcelin R, Crivelli V, Dacosta A, Roy-Tirelli A, Thorens B (2002) Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. Am J Physiol Endocrinol Metab 282:E834-E842
25. Negrel R, Dani C (2001) Cultures of adipose precursor cells and cells of clonal lines from animal white adipose tissue. Methods Mol Biol 155:225-237
26. Jager J, Gremeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF (2007) Interleukin-1β-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148:241-251
27. Johnson GB, Riggs BL, Platt JL (2004) A genetic basis for the "Adonis" phenotype of low adiposity and strong bones. FASEB J 18:1282-1284
28. Bruun JM, Helge JW, Richelsen B, Stallknecht B (2006) Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab 290:E961-E967
29. Norris AW, Chen L, Fisher SJ et al (2003) Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. J Clin Invest 112:608-618
30. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389:610-614
31. Moraes RC, Blondet A, Birkenkamp-Demtroeder K et al (2003) Study of the alteration of gene expression in adipose tissue of diet-induced obese mice by microarray and reverse transcription-polymerase chain reaction analyses. Endocrinology 144:4773-4782
32. Somm E, Henrichot E, Pernin A et al (2005) Decreased fat mass in interleukin-1 receptor antagonist-deficient mice: impact on adipogenesis, food intake, and energy expenditure.Diabetes 54:3503-3509
33. McCullough AJ (2004) The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 8:521-533 (viii)
34. Shi H, Kokoeva MV, Inouye K et al (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-3025
35. Song MJ, Kim KH, Yoon JM, Kim JB (2006) Activation of toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 346:739-745
36. Suganami T, Tanimoto-Koyama K, Nishida J et al (2007) Role of the toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27:84-91
37. Xu H, Sethi JK, Hotamisligil GS (1999) Transmembrane tumor necrosis factor (TNF)-alpha inhibits adipocyte differentiation by selectively activating TNF receptor 1. J Biol Chem 274:26287-26295
38. Petruschke T, Hauner H (1993) Tumor necrosis factor-alpha prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells. J Clin Endocrinol Metab 76:742-747
39. Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF (2002) Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes 51:1319-1336
40. Gual P, Le Marchand-Brustel Y, Tanti JF (2005) Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87:99-109
41. Hotamisligil GS, Peraldi P, Budavari A et al (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:665-668
42. Allan SM, Rothwell NJ (2001) Cytokines and acute neurodegeneration. Nat Rev Neurosci 2:734-744
43. Meier CA, Bobbioni E, Gabay C et al (2002) IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? J Clin Endocrinol Metab 87:1184-1188
44. Juge-Aubry CE, Somm E, Giusti Vet al (2003) Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes 52:1104-1110
45. Matsuki T, Horai R, Sudo K, Iwakura Y (2003) IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions. J Exp Med 198:877-888
46. Di Gregorio GB, Yao-Borengasser A, Rasouli N et al (2005) Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 54:2305-2313
47. Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA (1994) Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135:798-800
48. Somm E, Cettour-Rose P, Asensio C et al (2006) Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents. Diabetologia 387-393
49. Keshavarzian A, Choudhary S, Holmes EWet al (2001) Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J Pharmacol Exp Ther 299:442-448
50. Starkel P, Sempoux C, Leclercq I et al (2003) Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J Hepatol 39:538-546
51. Munford RS (2005) Detoxifying endotoxin: time, place and person. J Endotoxin Res 11:69-84